Recent OPDP enforcement letters target PR materials

11/27/2012

In a break from past practice, the FDA’s Office of Prescription Drug Promotion (OPDP) appears to be more closely scrutinizing drug companies’ public relations materials, as evidenced by two enforcement letters issued by OPDP last month citing a pitch letter and press releases. “Whether it’s a warning shot or a coincidence, it’s time for PR shops to brush up on the rules,” said Coalition for Healthcare Communication Executive Director John Kamp. Read more.

View Full Article in:

http://www.cohealthcom.org/2012/11/27/opdp-untitled-letters-on-pr-materials-surp...

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC